Bioventus Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: Nosenzo John (Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Phantom Profit Units	$		Class A Common Stock (66139)		Direct
Employee Stock
Option (right to buy)	$13.00	2031-02-10	Class A Common Stock (164500)		Direct

Footnotes

F1: The Phantom Profit Units will become redeemable on the one-year anniversary of the consummation of the Issuer's initial public offering.

F2: Each Phantom Profit Unit represents a contingent right to receive shares of Class A common stock.

F3: The option vests in four equal installments beginning on the first anniversary of the grant date.